Literature DB >> 6163873

Convenient assay for interferons.

S Rubinstein, P C Familletti, S Pestka.   

Abstract

A convenient assay for interferons based on reduction of cytopathic effect was developed. The number of manipulations and the lengths of the various incubation steps were reduced to a minimum. The assay is simple to perform and can be completed within 16 h. Moreover, it can be used with various types of cells and a variety of viruses.

Mesh：

Substances：

Year:  1981        PMID： 6163873      PMCID： PMC171063          DOI： 10.1128/JVI.37.2.755-758.1981

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  9 in total

1.  Studies on vaccinia virus plaque formation and its inhibition by interferon. III. A simplified plaque inhibition assay of interferon.

Authors:  J LINDENMANN; G E GIFFORD
Journal:  Virology       Date:  1963-03       Impact factor: 3.616

2.  Established kidney cell lines of normal adult bovine and ovine origin.

Authors:  S H MADIN; N B DARBY
Journal:  Proc Soc Exp Biol Med       Date:  1958-07

3.  Quantitative aspects of interferon-induced plaque reduction: kinetics of interferon action.

Authors:  G W Jordan
Journal:  Virology       Date:  1972-05       Impact factor: 3.616

4.  Semi-micro, dye-binding assay for rabbit interferon.

Authors:  J A Armstrong
Journal:  Appl Microbiol       Date:  1971-04

5.  Microassay for interferon, using [3H]uridine, microculture plates, and a multiple automated sample harvester.

Authors:  J Y Richmond; J Polatnick; R C Knudsen
Journal:  Appl Environ Microbiol       Date:  1980-04       Impact factor: 4.792

6.  The neuraminidase yield-reduction bioassay of human other interferons.

Authors:  J J Sedmak; S E Grossberg; P Jameson
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

7.  Human leukocyte interferon: production, purification to homogeneity, and initial characterization.

Authors:  M Rubinstein; S Rubinstein; P C Familletti; R S Miller; A A Waldman; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

8.  Vesicular stomatitis virus plaque production in monolayer cultures with liquid overlay medium: description and adaptation to a one-day, human interferon-plaque.

Authors:  J A Green; G J Stanton; J Goode; S Baron
Journal:  J Clin Microbiol       Date:  1976-12       Impact factor: 5.948

9.  Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature.

Authors:  J Vilcek; E A Havell
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205
  9 in total
  100 in total

1.  Poxvirus-induced immunostimulating effects on porcine leukocytes.

Authors:  V Fachinger; T Schlapp; W Strube; N Schmeer; A Saalmüller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Extracellular 2'-5' oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity.

Authors:  Helle Kristiansen; Christina A Scherer; Maralee McVean; Shawn P Iadonato; Susanne Vends; Karthiga Thavachelvam; Thomas B Steffensen; Kristy A Horan; Thomas Kuri; Friedemann Weber; Søren R Paludan; Rune Hartmann
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

3.  In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines.

Authors:  Philip I Marcus; John M Ngunjiri; Margaret J Sekellick; Leyi Wang; Chang-Won Lee
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

4.  Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo.

Authors:  Fatema A Legrand; Paulo H Verardi; Kenneth S Chan; Yue Peng; Leslie A Jones; Tilahun D Yilma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-10       Impact factor: 11.205

5.  Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors.

Authors:  Marta Marchetti; Marie-Noelle Monier; Alexandre Fradagrada; Keith Mitchell; Florence Baychelier; Pierre Eid; Ludger Johannes; Christophe Lamaze
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

6.  Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance.

Authors:  B E Henricson; W R Benjamin; S N Vogel
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

7.  Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways.

Authors:  Jiangao Zhu; Xiaopei Huang; Yiping Yang
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 8.  Clinical pharmacokinetics of interferons.

Authors:  R J Wills
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

9.  NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.

Authors:  Agnès Billecocq; Martin Spiegel; Pierre Vialat; Alain Kohl; Friedemann Weber; Michèle Bouloy; Otto Haller
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures.

Authors:  P B Fisher; A F Miranda; L E Babiss; S Pestka; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.